EPISODE · Dec 4, 2023 · 6 MIN
Sickle cell gene-editing treatment poised for FDA approval
from POLITICO's Pulse Check · host POLITICO
The FDA is close to a decision on a landmark one-time gene-editing treatment for patients with sickle cell disease and another blood disorder. Host Kelly Hooper talks with POLITICO health care reporter Lauren Gardner about how the therapy works, its safety profile, who will be eligible for it and the significant challenges around affordability and access. Learn more about your ad choices. Visit megaphone.fm/adchoices
What this episode covers
The FDA is close to a decision on a landmark one-time gene-editing treatment for patients with sickle cell disease and another blood disorder. Host Kelly Hooper talks with POLITICO health care reporter Lauren Gardner about how the therapy works, its safety profile, who will be eligible for it and the significant challenges around affordability and access. Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
Sickle cell gene-editing treatment poised for FDA approval
No transcript for this episode yet
Similar Episodes
Jun 20, 2026 ·2m
Jun 20, 2026 ·2m
Jun 15, 2026 ·3m
Jun 15, 2026 ·3m
Jun 14, 2026 ·2m
Jun 14, 2026 ·2m